Phase I/II trial of chemoradiotherapy with concurrent S‐1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|106|10|1414-1420

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.10, 2015-10, pp. : 1414-1420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial of chemoradiotherapy with S‐1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)

By  

Cancer Science, Vol. 106, Iss. 6, 2015-06 ,pp. : 726-733

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS‐PC Study

By  

Cancer Science, Vol. 106, Iss. 7, 2015-07 ,pp. : 883-890

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized study of low‐dose versus standard‐dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)

By  

Cancer Science, Vol. 106, Iss. 4, 2015-04 ,pp. : 407-412

John Wiley & Sons Inc

Access to resources Recommend Favorite

Suitability of mixed-mode I/II assessment methods for implementation into the SINTAP procedure

By Pirondi A.  

Engineering Fracture Mechanics, Vol. 70, Iss. 13, 2003-09 ,pp. : 1597-1609

Elsevier

Access to resources Recommend Favorite

Influence of the Matrix Toughness in Carbon-Epoxy Composites Subjected to Delamination under Modes I, II, and Mixed I/II

By Bonhomme J.  

Mechanics of Advanced Materials and Structures, Vol. 20, Iss. 8, 2013-09 ,pp. : 679-686

Taylor & Francis Ltd

Access to resources Recommend Favorite